Innovative Discovery & Commercialization
Drug discovery and research is an important part of the Piramal business. The company has more than 115 issued patents and 395 pending patent applications in several countries. The patents and pending applications cover a wide variety of areas across multiple discovery and development programs including compositions of matter (NCEs and natural products), methods of treatment, biomarkers, pharmaceutical compositions, drug delivery systems, etc.
The Board of Piramal Enterprises has approved the scheme of De-merger of the New Chemical Entity (NCE) Research Unit of Piramal Life Sciences Limited (PLSL) into Piramal Enterprises Limited. Under the proposed De-merger scheme, each shareholder of PLSL will be entitled to one fully paid up equity share of Rs. 2 each of PHL for every four equity shares of Rs. 10 each held in PLSL. Since April 2007, when PLSL was de-merged from PHL as an independent discovery research company, it has made significant progress. The pipeline of R&D programs has increased from nine to twenty four with nine additional programs moving into Phase I/II clinical trials and two additional program moving into Phase II clinical trials. Subsequent to the significant progress that PLSL has made, the risk profile of NCE R&D activity has reduced considerably.
Read more about this topic: Piramal Healthcare
Famous quotes containing the words innovative and/or discovery:
“A conventional good read is usually a bad read, a relaxing bath in what we know already. A true good read is surely an act of innovative creation in which we, the readers, become conspirators.”
—Malcolm Bradbury (b. 1932)
“Next to the striking of fire and the discovery of the wheel, the greatest triumph of what we call civilization was the domestication of the human male.”
—Max Lerner (b. 1902)